IDEXX Laboratories, Inc. (IDXX)

Acerca de IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Al 3 de noviembre de 2026, la acción de IDEXX Laboratories, Inc. (IDXX) avanzó ligeramente a $674.06, un alza de 0.36% (+$2.42) frente al cierre anterior. En la sesión, las acciones han operado entre $655.51 y $676.44. Eso ubica a IDXX cerca de la mitad de su rango de 52 semanas, de $500.61 a $769.98. IDEXX Laboratories, Inc. opera en el sector de in vitro & in vivo diagnostic substances y tiene una capitalización de mercado de aproximadamente $43.42 mil millones, con cerca de 348.5 mil acciones negociadas.

Últimas noticias de IDXX

• Idexx Laboratories (IDXX) Crossed Above the 200-Day Moving Average: What That Means for InvestorsYahoo Finance· 3 nov, 8:30 a.m. ET
• Company News for Nov 3, 2026Yahoo Finance· 3 nov, 8:22 a.m. ET
• US Stock Market Today: S&P 500 Futures Slip On Firm Manufacturing And Jobs FocusYahoo Finance· 3 nov, 8:13 a.m. ET
• Review & Preview: WhiplashYahoo Finance· 2 nov, 7:55 p.m. ET
• IDEXX stock soars 21.9% after earnings beat and higher outlookthestreet.com· 2 nov, 7:00 p.m. ET
• Non-AI stock surges 20% after earnings beat and raised outlookthestreet.com· 2 nov, 6:14 p.m. ET
• Earnings Calendar and Analysis for This Weekkiplinger.com· 2 nov, 5:19 p.m. ET
• US Equity Markets Mixed as Technology Sell-Off Continues, Crude Oil Prices DipYahoo Finance· 2 nov, 4:15 p.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de IDXX en un solo lugar? Crea una cuenta gratis →

• $IDXX target: $771.75

  @abramso_com· 3 nov, 9:37 a.m. ET· Alcista

• ☀️ Plan for Tuesday, Nov 3, before my first order. Paper account. ⏰ Late today: a power cut at my base. Still before I trade. 🌍 Equal-weight S&P +0.76% yesterday while tech fell 2.95%. Money keeps leaving AI and chips for staples, financials, healthcare. Midterms today, A…

  @rafik_ai_trader· 3 nov, 9:21 a.m. ET

• $IDXX Share Price: $671.84 Contract Selected: Apr 16, 2027 $670 Calls Buy Zone: $52.71 – $65.11 Target Zone: $95.73 – $117.01 Potential Upside: 72% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/

  @SuperGreenToday· 3 nov, 7:59 a.m. ET

• $IDXX Q3 results Nov 2 before the open: revenue $1.214B (+10%), EPS $4.01 (+18%); FY26 EPS outlook raised to $14.96–15.16. Shares closed at $671.64 on Monday, above the 50-day SMA ($536.56) and above the 200-day ($572.42), near the top of its 20-day range ($501.17–$673.19). Pr…

  @Merlintrader· 3 nov, 7:44 a.m. ET

• $IDXX jumped about 22% on Monday, November 2, 2026 after revenue rose 10% to $1.21B and it raised its full-year revenue outlook to $4.74B-$4.77B. EPS (profit per share) was about $4.01 against roughly $3.71 expected. A stock's value is not fixed. It gets recalculated sever…

  @Techdamentals· 2 nov, 10:21 p.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →